229 related articles for article (PubMed ID: 5971576)
21. [Use of hypoglycemic sulfonamides in the clinic].
Martin E
Actual Pharmacol (Paris); 1968; 21():191-212. PubMed ID: 4888765
[No Abstract] [Full Text] [Related]
22. [Increased risk of cardiovascular complications with oral hypoglycemic agents?].
Mueller R
Acta Diabetol Lat; 1970; 7(5):805-23. PubMed ID: 4949515
[No Abstract] [Full Text] [Related]
23. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH
Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812
[TBL] [Abstract][Full Text] [Related]
24. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
Seltzer HS
Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
[No Abstract] [Full Text] [Related]
25. The comparative clinical effectiveness of tolbutamide and acetohexamide.
Duncan TG; Smith JB; Duncan GG
Metabolism; 1968 Mar; 17(3):218-25. PubMed ID: 4867884
[No Abstract] [Full Text] [Related]
26. Tolanase - a sulphonylurea antidiabetic agent.
Drug Ther Bull; 1968 Mar; 6(7):27-8. PubMed ID: 5655488
[No Abstract] [Full Text] [Related]
27. The UGDP study.
Salsburg DS
JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
[No Abstract] [Full Text] [Related]
28. Oral hypoglycaemic drugs.
Br Med J; 1969 Mar; 1(5647):829-31. PubMed ID: 5774083
[No Abstract] [Full Text] [Related]
29. Oral therapy in diabetes.
Bloom A
J R Coll Physicians Lond; 1972 Oct; 7(1):61-8. PubMed ID: 4627653
[No Abstract] [Full Text] [Related]
30. Antidiabetic agents and vascular events.
Keen H
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
[No Abstract] [Full Text] [Related]
31. Clinical experience with acetohexamide an oral hypoglycemic, anti-diabetic agent.
Bergen SS
Pa Med; 1970 Aug; 73(8):49-52. PubMed ID: 4947380
[No Abstract] [Full Text] [Related]
32. Editorial: Oral hypoglycemic drugs.
Scoville AB
J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
[No Abstract] [Full Text] [Related]
33. Oral sulphonylureas in the management of diabetes.
Jackson WP
S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
[No Abstract] [Full Text] [Related]
34. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
MOSS JM; DELAWTER DE; GALLAGHER EJ
Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
[No Abstract] [Full Text] [Related]
35. Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
Goetz FC
Postgrad Med; 1972 Jul; 52(1):63-8. PubMed ID: 5067890
[No Abstract] [Full Text] [Related]
36. The prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes.
Feldman R; Crawford D
Adv Metab Disord; 1970; 1():Suppl 1:443+. PubMed ID: 5446911
[No Abstract] [Full Text] [Related]
37. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
[No Abstract] [Full Text] [Related]
38. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.
Abramson E; Arky RA
Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062
[No Abstract] [Full Text] [Related]
39. Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous?
Constam GR
Diabetologia; 1971 Aug; 7(4):237-9. PubMed ID: 5093706
[No Abstract] [Full Text] [Related]
40. [Clinico-statistical studies of the use of oral hypoglycemic agents in the therapy of diabetes: critical evaluation of their effectiveness and tolerance].
Torri A; Zanni A; Roncaia R; Di Saverio S
Clin Ter; 1977 Jul; 82(1):45-56. PubMed ID: 409583
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
